Feb. 11 at 5:16 PM
$CSDX one to look into asap tick tock. Their CS Protect-Hydrogel is currently under FDA review
High value/low competition niche(hydrogel spacers)
•SpaceOAR™ Hydrogel System acquired by
$BSX Boston Scientific for
$500M
•Barrigel® acquired by Telefex
$TFX for
$600M
And literally no other direct competitors in market
This is a pretty big OTC play. High value/low competition niche(hydrogel spacers), which seen major buyouts in the past. In the range of
$500M-
$600M.
Not your typical OTC play. The potential is just massive on this one